The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

11
THE COMMONWEALTH FUND The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund AcademyHealth Annual Research Meeting June 27, 2006

description

The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries. Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund AcademyHealth Annual Research Meeting June 27, 2006. What Do We Want From The New Drug Benefit?. - PowerPoint PPT Presentation

Transcript of The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

Page 1: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE COMMONWEALTH

FUND

The Potential Impact of theNew Prescription Drug Benefit on

Medicare BeneficiariesStuart Guterman

Director, Program on Medicare’s FutureThe Commonwealth Fund

AcademyHealth Annual Research MeetingJune 27, 2006

Page 2: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

What Do We Want FromWhat Do We Want FromThe New Drug Benefit?The New Drug Benefit?

• Continuity—Will beneficiaries with coverage before have corresponding (or better) coverage under Part D?

• Availability—Will beneficiaries be able to find a plan that’s best for them?

• Access—Will beneficiaries be able to get the drugs they need?

Page 3: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Concern AboutConcern AboutVulnerable PopulationsVulnerable Populations

• Medicaid recipients• Other low-income beneficiaries• Nursing home residents• Frail and disabled beneficiaries• Chronically ill beneficiaries• Racial and ethnic minorities

Page 4: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Source of Prescription Drug CoverageSource of Prescription Drug Coveragefor Community-Dwellingfor Community-Dwelling

Medicare Beneficiaries, 1998-2000Medicare Beneficiaries, 1998-2000

24.7

16.5

10.5

34.8

11.815.8

0

5

10

15

20

25

30

35

40

45

50

None Medicare

HMO

Medicaid Employer Medigap Other

Source: B. Stuart, et al. “Riding the Roller Coaster: The Ups and Downs in Out-of-Pocket Spending Under the Standard Medicare Drug Benefit.” Health Affairs. 24(4). (July/August 2005): 1025.

Percent

Page 5: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Source of Prescription Drug Coverage for Source of Prescription Drug Coverage for Medicare Beneficiaries Residing in Nursing Medicare Beneficiaries Residing in Nursing Homes, 2001Homes, 2001

No Rx coverage 20%

Other supplement

with Rx coverage

9 %

Other supplement with Rx coverage unknown

15 %

Full Medicaid 56%

Source: Stuart, B. et al. “Coverage and Use of Prescription Drugs in Nursing Homes: Implications for the Medicare Modernization Act.” Medical Care. 44(3). (March 2006): 243.

Page 6: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Coverage, Income, and Chronic Illness Are Coverage, Income, and Chronic Illness Are Factors in Adherence toFactors in Adherence to

Prescribed Drug RegimensPrescribed Drug Regimens

26.3

36.835.2 34.9

0

10

20

30

40

50

All seniors No prescription drug

coverage

Low income Three or more chronic

conditions

Source: Safran, D. et al. “Prescription Drug Coverage and Seniors: Findings From a 2003 National Survey.” Health Affairs Web exclusive. April 19, 2005.

Percent of Seniors Not Adhering to Prescribed Drug Regimens

Page 7: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Beneficiary Out-of-Pocket Costs Under the Beneficiary Out-of-Pocket Costs Under the Medicare Part D Standard Benefit, 2006Medicare Part D Standard Benefit, 2006

0

1000

2000

3000

4000

5000

6000

7000

8000

9000

10000

0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000

Total Covered Drug Cost

Total Out-of-pocket Out-of-pocket+premium

Out-of-Pocket Cost

Page 8: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Deductibles Offered by Medicare Stand-Deductibles Offered by Medicare Stand-Alone Prescription Drug Plans, 2006Alone Prescription Drug Plans, 2006

$0

58% of plans

$50-$100

8%

$250

34% of plans

$150-$175

0%

Source: CMS, PDP Landscape of Local Plans Source File as of November 15, 2005.

Page 9: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Availability of Coverage in theAvailability of Coverage in thePart D “Coverage Gap”Part D “Coverage Gap”

No coverage

84% of plans

Generics and Brand

3% of plans

Generics only

13% of plans

Source: CMS, PDP Landscape of Local Plans Source File as of November 15, 2005.

Page 10: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

Average Plan Premiums by Deductible and Average Plan Premiums by Deductible and Availability of Coverage in theAvailability of Coverage in the

Part D “Coverage Gap”Part D “Coverage Gap”

$30.74$35.91

$48.09

$61.28

$0.00

$10.00

$20.00

$30.00

$40.00

$50.00

$60.00

$70.00

$250 deductibleand no

coverage

$0 deductibleand no

coverage

$0 deductibleand generics

only

$0 deductibleand generics

+brand

Plan Premium

Source: CMS, PDP Landscape of Local Plans Source File as of November 15, 2005.

Page 11: The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

THE

COMMONWEALTH FUND

The Papers in This Session The Papers in This Session • Defining and Measuring Performance of Medicare Prescription Drug

Plans’ FormulariesTanisha Carino, Ph.D., Avalere Health

• Following Doctors’ Orders…or Not: Medication Adherence Among Medicare Beneficiaries and What We Can Expect Part D Coverage to AccomplishDana Gelb Safran, Ph.D., Tufts/New England Medical Center

• Drug Coverage, Disease Burden, and the Intensity of Medication

Use among Medicare Beneficiaries Bruce Stuart, Ph.D., University of Maryland at Baltimore

• Discussant:Scott Young, MD, AHRQ